Jump to content

Biomedical


These projects build on the multi-functionality allowed by 2DMs to demonstrate the advantages of combining e.g. biocompatibility, chemical stability, (bio-) sensing and actuating, and integration with flexible electronic technologies, in addition to versatile surface chemistry (for interface with biology) which allows for continuous health monitoring and built-in pharmacological interventions.

The aim is to offer new technology solutions exploiting the unique properties of 2D materials (2DM) that would reduce cost and increase the efficacy of diagnostics or therapies, or provide new diagnostics or therapies for which there is currently no solution. It would strengthen Europe’s industrial position in, early diagnostics, disease prediction and prevention, disease monitoring and reducing hospitalization time.

Projects

MUNASET


Proteases recently emerged as a promising new class of biomarkers with a broad diagnostic, prognostic and therapeutic potential for different human diseases including neurological and psychiatric diseases, several types of cancer, and immune system disorders. However, there is a lack of tools for real-time activity analysis of disease-related protease biomarkers.

2D-BioPAD


2D-BioPAD is a cost-effective, non-invasive point of care/self-testing tool for the early and accurate prognosis (assistive diagnosis) of Alzheimer's Disease, with special focus on earlier stages such as Subjective or Mild Cognitive Impairment (SCI/MCI).

Latest articles

Jack Maughan Postdoctoral Researcher in Tissue Engineering & Neural Interfacing @ TCD, RCSI & AMBER Poster Award Winner on sustainable use of graphene Graphene Week 2024
Graphene Week / neuroscience / Graphene / poster awards / Biomedical

Jack Maughan’s Work at the Edge of Graphene and Neuroscience


At the crossroads of cutting-edge materials science and advanced biomedical engineering, Jack Maughan is building tools that could reshape how we treat and interact with the brain. A postdoctoral researcher with a background in nanoscience and tissue engineering, Jack is exploring how graphene-based microneedles can enable next-generation neural interfaces devices that could one day treat neurological disorders, restore movement, and even enhance human-machine communication.

By Graphene Flagship / 23 May 2025
Show all news